Font Size: a A A
Keyword [Non-small]
Result: 161 - 180 | Page: 9 of 10
161. δ-catenin Promotes Malignant Phenotype Of Non-small Cell Lung Cancer By Non-competitive Binding To E-cadherin With P120ctn In Cytoplasm
162. Involvement Of Hsa-miR-125a-3p And Hsa-miR-125a-5p In Non-small Cell Lung Cancer
163. The Relationship Between HDPR1 With Catenin Family Members Each Other In Non-Small Cell Lung Cancer
164. Initial Partial Response And Stable Disease Indicate Similar Progression-free Survival For Chemotherapeutical Patients With Advanced Non-small Cell Lung Cancer
165. Expression Of 14-3-3zeta And Its Influence On Tumor Development And Apoptosis In Stage T1 Non-small Cell Lung Cancer
166. Expression And Clinical Significance Of Survivin,P53 And Bcl-2 In ⅢA Non-small Cell Lung Cancer(NSCLC)before And After Neoadjuvant Chemotherapy
167. The Mechanism Of Gefitinib Resistance Induced By Hepatocyte Growth Factor In Sensitive Non-small Lung Cancer Cells
168. Hepatocellular Careinoma HepG2 Therapy Mediated By Tumor Suppressor Of Non-small Cell Lung Cancer 1
169. Effect Of NKTm Cells Plus Cisplatin/cetuximab Treatment On NSCLC Cells In Vitro
170. Concurrent Chemoradiotherapy For Locally Advanced Non-small Cell Lung Cancer Clinical Outcomes Of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy
171. Expression Of Nm23 And E-cadherin In Stage Ⅰ Non-small Cell Lung Cancer, And Their Relationship With Lymph Node Micrometastasis And Prognosis
172. Anti-tumor Activity Of Fucoxanthin, An Active Ingredient Of Kelp Extract, Against Human NSCLC And Its Mechanism
173. Detection And Identification Of Serum Biomarkers Of Non-small Cell Lung Cancer
174. The Effect And Mechanism Of Inhibition Of Human Non-small Lung Cancer Cells By Vascular Basement Membrance Derived Multifunctional Peptide
175. Research Of Health Technology Assessment For PET-CT In The Diagnosis Of Non-small Cell Lung Cancer
176. The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
177. The Changes Of CD4~+CD25~+ Regulatory T Cells Of Non Small-cell Lung Cancer Patients And The Effects Of CpG ODN
178. Anti-Paclitaxel Resistance Effect Of Somatostatin Receptors Mediated Targeted Therapy On Non-small Cell Lung Cancer Cells And Its Possible Mechanisms
179. Functional Imaging And Proteomics Techniques Predict Sensitivity To Chemoradiotherapy In Non-Small Cell Lung Cancer
180. Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to